Logo image of DMRC

DIGIMARC CORP (DMRC) Stock Fundamental Analysis

USA - NASDAQ:DMRC - US25381B1017 - Common Stock

9.69 USD
+0.07 (+0.73%)
Last: 10/3/2025, 8:00:01 PM
9.69 USD
0 (0%)
After Hours: 10/3/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, DMRC scores 3 out of 10 in our fundamental rating. DMRC was compared to 281 industry peers in the Software industry. While DMRC seems to be doing ok healthwise, there are quite some concerns on its profitability. DMRC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DMRC had negative earnings in the past year.
DMRC had a negative operating cash flow in the past year.
In the past 5 years DMRC always reported negative net income.
DMRC had a negative operating cash flow in each of the past 5 years.
DMRC Yearly Net Income VS EBIT VS OCF VS FCFDMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -64.78%, DMRC is doing worse than 86.48% of the companies in the same industry.
DMRC's Return On Equity of -84.66% is on the low side compared to the rest of the industry. DMRC is outperformed by 76.16% of its industry peers.
Industry RankSector Rank
ROA -64.78%
ROE -84.66%
ROIC N/A
ROA(3y)-53.7%
ROA(5y)-52%
ROE(3y)-66.35%
ROE(5y)-62.86%
ROIC(3y)N/A
ROIC(5y)N/A
DMRC Yearly ROA, ROE, ROICDMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 61.88%, DMRC is in line with its industry, outperforming 40.57% of the companies in the same industry.
DMRC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DMRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-0.6%
DMRC Yearly Profit, Operating, Gross MarginsDMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

6

2. Health

2.1 Basic Checks

DMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DMRC has more shares outstanding
DMRC has more shares outstanding than it did 5 years ago.
DMRC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DMRC Yearly Shares OutstandingDMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
DMRC Yearly Total Debt VS Total AssetsDMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

DMRC has an Altman-Z score of -1.04. This is a bad value and indicates that DMRC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DMRC (-1.04) is worse than 75.44% of its industry peers.
DMRC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.04
ROIC/WACCN/A
WACC11.34%
DMRC Yearly LT Debt VS Equity VS FCFDMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M

2.3 Liquidity

DMRC has a Current Ratio of 2.66. This indicates that DMRC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of DMRC (2.66) is better than 74.38% of its industry peers.
DMRC has a Quick Ratio of 2.66. This indicates that DMRC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.66, DMRC is in the better half of the industry, outperforming 74.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.66
DMRC Yearly Current Assets VS Current LiabilitesDMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.67% over the past year.
DMRC shows a decrease in Revenue. In the last year, the revenue decreased by -8.06%.
DMRC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.82% yearly.
EPS 1Y (TTM)4.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.17%
Revenue 1Y (TTM)-8.06%
Revenue growth 3Y13.15%
Revenue growth 5Y10.82%
Sales Q2Q%-22.82%

3.2 Future

DMRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.47% yearly.
DMRC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.36% yearly.
EPS Next Y39.91%
EPS Next 2Y37.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.94%
Revenue Next 2Y-8.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DMRC Yearly Revenue VS EstimatesDMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DMRC Yearly EPS VS EstimatesDMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DMRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DMRC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DMRC Price Earnings VS Forward Price EarningsDMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DMRC Per share dataDMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as DMRC's earnings are expected to grow with 37.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DMRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIGIMARC CORP

NASDAQ:DMRC (10/3/2025, 8:00:01 PM)

After market: 9.69 0 (0%)

9.69

+0.07 (+0.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)10-29 2025-10-29
Inst Owners63.73%
Inst Owner Change-61.57%
Ins Owners13.28%
Ins Owner Change3.62%
Market Cap210.08M
Analysts80
Price Target20.4 (110.53%)
Short Float %11.45%
Short Ratio8.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.17%
Min EPS beat(2)-44.44%
Max EPS beat(2)28.1%
EPS beat(4)2
Avg EPS beat(4)-4.58%
Min EPS beat(4)-44.44%
Max EPS beat(4)28.1%
EPS beat(8)6
Avg EPS beat(8)5.28%
EPS beat(12)10
Avg EPS beat(12)8.98%
EPS beat(16)13
Avg EPS beat(16)8.54%
Revenue beat(2)1
Avg Revenue beat(2)0.31%
Min Revenue beat(2)-4.21%
Max Revenue beat(2)4.83%
Revenue beat(4)1
Avg Revenue beat(4)-5.37%
Min Revenue beat(4)-13.29%
Max Revenue beat(4)4.83%
Revenue beat(8)5
Avg Revenue beat(8)-2.29%
Revenue beat(12)7
Avg Revenue beat(12)-1.64%
Revenue beat(16)8
Avg Revenue beat(16)-1.65%
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.39%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.92
P/FCF N/A
P/OCF N/A
P/B 4.52
P/tB 12.59
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS1.64
BVpS2.14
TBVpS0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.78%
ROE -84.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.88%
FCFM N/A
ROA(3y)-53.7%
ROA(5y)-52%
ROE(3y)-66.35%
ROE(5y)-62.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-0.6%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.72%
Cap/Sales 2.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.66
Altman-Z -1.04
F-Score5
WACC11.34%
ROIC/WACCN/A
Cap/Depr(3y)12.64%
Cap/Depr(5y)37.08%
Cap/Sales(3y)2.89%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.17%
EPS Next Y39.91%
EPS Next 2Y37.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.06%
Revenue growth 3Y13.15%
Revenue growth 5Y10.82%
Sales Q2Q%-22.82%
Revenue Next Year-15.94%
Revenue Next 2Y-8.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.99%
OCF growth 3YN/A
OCF growth 5YN/A